help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2008-2040
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poitou, C.
Right arrow Articles by Clément, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poitou, C.
Right arrow Articles by Clément, K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Related Collections
Right arrow Lipid
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 94, No. 5 1810-1817
Copyright © 2009 by The Endocrine Society

Role of Serum Amyloid A in Adipocyte-Macrophage Cross Talk and Adipocyte Cholesterol Efflux

Christine Poitou1, Adeline Divoux1, Aurélie Faty, Joan Tordjman, Danielle Hugol, Abdelhaim Aissat, Mayoura Keophiphath, Corneliu Henegar, Stéphane Commans and Karine Clément

Institut National de la Santé et de la Recherche Médicale (C.P., A.D., J.T., M.K., C.H., K.C.), U872 team7, Nutriomique, Cordelier Research Center, Paris 75006, France; University Pierre et Marie Curie-Paris-6 (C.P., A.D., J.T., M.K., C.H., K.C.), Unité Mixte de Recherche en Santé, Paris 75006, France; Assistance Publique-Hôpitaux de Paris, Endocrinology and Nutrition Department (C.P., C.H., K.C.), Pitié Salpêtrière hospital, Paris 75013, France; GlaxoSmithKline Laboratory (A.F., S.C.), Research Centre metabolic Pathways GlaxoSmithKline, 91951 Les Ulis, France; and Assistance Publique-Hôpitaux de Paris, Cytopathology (D.H.) and Surgery (A.A.) Departments, Hotel Dieu Hospital Paris F-75004, France

Address all correspondence and requests for reprints to: Christine Poitou, M.D., Ph.D., Institut National de la Santé et de la Recherche Médicale Nutriomique U872 (Eq 7), University Pierre et Marie Curie-Paris6, Cordelier Research Center, 15 rue de l’école de médecine, 75006 Paris, France. E-mail: christine.poitou-bernert{at}psl.aphp.fr.

Context: Acute phase serum amyloid A (A-SAA) is secreted by hepatocytes in response to injury and is regulated by proinflammatory cytokines. In obese humans, adipocytes are also a major contributor to circulating A-SAA levels.

Objective: We aimed to investigate the role and regulation of A-SAA in human adipose tissue (AT).

Design: An approach combining microarrays and the FunNet bioinformatics tool was applied to human AT fractions (i.e. adipocytes vs. stroma vascular fraction) to hypothesize genes and functions related to A-SAA. Experiments with human AT from 37 obese subjects and human multipotent adipose-derived stem (hMADS) cells were used to confirm the microarray driven hypotheses.

Results: Microarray analysis highlighted the relationship between A-SAA and stroma vascular fraction inflammatory genes, and between A-SAA and adipocyte-expressed ATP-binding cassette (ABC) transporters. We confirmed that serum amyloid A (SAA) protein is expressed in sc AT of obese subjects (n = 37, body mass index = 49.3 ± 1.5 kg/m2) and showed that SAA protein expression correlated with adipocyte size (R = 0.44; P = 6.10–3), macrophage infiltration (R = 0.61; P = 10–4), and ABC subfamily A1 protein expression (R = 0.43; P = 9.10–3). IL-1β, TNF-{alpha}, and human AT macrophage-conditioned medium significantly induced A-SAA secretion (from 2.6 to 7.6 fold) in hMADS cells. Recombinant SAA induced cholesterol ABC subfamily A1-dependent efflux from hMADS adipocytes by 4.3-fold in a dose-dependent manner.

Conclusion: This work provides original insight suggesting that A-SAA is a player in the dialogue between hypertrophied adipocytes and macrophages through its regulation of adipocyte cholesterol efflux.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society